Robotic surgery represents one of the most innovative breakthroughs for treating patients with malignant pleural mesothelioma. Its development has provided new options for patients whose tumors were so inaccessible that they would previously have been referred for palliative care. In the skilled hands of some of the world’s most accomplished thoracic surgeons, minimally invasive robotic
Dr. Anthony W. Kim is an internationally respected thoracic oncologist and surgeon. He leads the thoracic surgery division and program at Keck Medicine of University of Southern California and at the USC Norris Comprehensive Cancer Center. He is an expert in thoracic oncology, including in treating malignant pleural mesothelioma and lung cancer, specializing in minimally
Dr. Scott M. Atay specializes in thoracic surgery with an emphasis on malignant diseases including pleural mesothelioma, lung cancer, and esophageal cancer. Committed to delivering compassionate, high-quality care driven by the most up-to-date scientific evidence, he prioritizes offering patients with both early and advanced-stage disease multimodality treatment that combines surgery with chemotherapy, immunotherapy, and radiation
The Massachusetts Attorney General’s Office has issued 104 indictments to a developer it fears raised the risk of malignant mesothelioma to thousands. The company is accused of illegally demolishing a former elementary school, spreading asbestos dust to a large neighborhood and exposing its own workers to the carcinogenic material at the same time.
Dr. Matthew A. Gubens is a thoracic oncologist at the UCSF Thoracic Surgery and Oncology Clinic at the Helen Diller Family Comprehensive Cancer Center. He specializes in treating patients diagnosed with non-small cell lung cancer, small cell lung cancer, thymoma and thymic carcinoma, and malignant pleural mesothelioma. Dr. Gubens is actively involved in research seeking
Dr. Hitesh Batra is an interventional pulmonologist with special interest in pleural diseases, including malignant pleural mesothelioma. He is Director of the University of Alabama at Birmingham Hospital’s Interventional Pulmonology and Pleural Disease program, the state’s first and only interventional pulmonary program. Partnering with a multidisciplinary team of physicians and other healthcare professionals, he offers
Dr. Julie Renee Brahmer is an international leader in the development of new therapies for the treatment and prevention of lung cancer and malignant mesothelioma. Board certified in Internal Medicine (Medical Oncology), her positions at the Sidney Kimmel Comprehensive Cancer Center include being Co-Director of the Cancer Immunology Program and the Director of Thoracic Oncology.
Dr. Heather Wakelee is a clinical investigator who concentrates her efforts on lung cancer, malignant mesothelioma, and other thoracic malignancies. After years developing research program and being physician lead for Stanford’s thoracic malignancies clinical research group, she took on the role of Deputy Director of the Stanford Cancer Institute. Dr. Wakelee is actively and personally
Dr. David Tom Cooke is Professor and Founding Chief of UC Davis Health Center’s Division of General Thoracic Surgery. He specializes in complex general thoracic surgery and thoracic oncology, with special clinical interests including lung cancers and surgery for malignant mesothelioma. Dr. Cooke is a national leader in robotic thoracic surgery. His skills include minimally
Dr. Jonathan Wesley Riess is a thoracic oncologist at the UC Davis Health Medical Center. As Medical Director of Thoracic Oncology, he relies on advances in diagnostics, targeted therapies, and immunotherapy in the care of patients with malignant mesothelioma, lung cancer, and other thoracic cancers. In addition to his clinical care, he is also actively